98 studies on Thymosin class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This review highlights the critical role of pineal gland peptides in potentially combating age-related immune decline by preserving thymus function. The finding that epithalamin and epitalon are particularly effective…
This review significantly advances our understanding of the neuroimmunomodulatory axis and its role in aging, particularly highlighting the potent geroprotective potential of pineal peptides. The finding that pineal p…
This research uncovers a novel, indirect antitumor mechanism for Thymosin alpha-1 that goes beyond general immune modulation. For individuals using TA in cancer support protocols, this suggests a specific benefit in d…
If successful, this trial could establish **Thymosin alpha 1 as a first-line preventative therapy for infected pancreatic necrosis (IPN)**, a deadly complication of acute pancreatitis. This would represent a major shi…
This research suggests Tα1 could be a valuable adjunct therapy for managing the systemic, non-pulmonary complications of Cystic Fibrosis (CF). For patients and clinicians, this points to a potential strategy for addre…
This research implies that the effectiveness of immunomodulatory peptides like Thymosin alpha-1 may not be uniform across genders. For individuals using Tα1 for immune support, particularly in the context of viral inf…
This comprehensive review underscores the significant, yet often underappreciated, therapeutic potential of Thymosin alpha 1 as a broad-spectrum immune modulator with direct antiviral capabilities. The findings strong…
These findings provide a mechanistic rationale for using **Thymosin alpha 1 (Tα1)** in the management of **COVID-19** and potentially other conditions characterized by a cytokine storm. For clinicians and individuals …
For individuals considering Thymosin-α1 as an adjunctive therapy for mild or moderate viral illnesses, this study provides a nuanced perspective. The findings suggest that Tα1 may not be the preventative agent against…
This study provides a preclinical rationale for combining the immunomodulatory peptide **Thymosin alpha 1** with the chemotherapeutic agent Gemcitabine for treating **NNKTL**. The synergy suggests that Tα1 may enhance…
**Postpartum patients on ECMO represent one of the highest-complexity critical care scenarios**, combining altered coagulation physiology, postoperative hemodynamics, and immune dysregulation driven by COVID-19. The i…
This unique case highlights the critical need to understand atypical immune responses in immunocompromised individuals with SARS-CoV-2 and other viral infections. The absence of antibody production in this long-term a…
This review underscores the significant potential of Thymosin α-1 (Tα-1) to revolutionize cancer treatment strategies. By enhancing the body's natural anti-tumor immune response and potentially mitigating the side eff…
This systematic review underscores the significant therapeutic potential of thymosin drugs as a valuable addition to the current arsenal against lung cancer. Their ability to modulate the immune system offers a distin…
Acute type A aortic dissection (ATAAD) surgery carries a high risk of complications, and current treatments lack targeted strategies for immune modulation to prevent organ failure. A successful outcome for the PANDA I…
The development of Refnot represents a significant advancement, offering a novel and potentially safer strategy to combat the multifaceted challenges of age-related immune decline and chronic inflammation. By combinin…
This compelling case report underscores the critical need for heightened clinical vigilance and careful patient selection when considering combination therapies involving immune checkpoint inhibitors and other immunom…
This research is critically important for anti-doping efforts in sports, as it provides a definitive chemical signature for a suspected performance-enhancing substance. By identifying Ac-LKKTETQ as the active componen…
This review provides a crucial overview of the current challenges and solutions in anti-doping science. For athletes and support personnel, it reinforces the sophistication and reach of modern testing protocols, makin…
For athletes and individuals using performance-enhancing peptides, this review underscores that sophisticated detection methods are already established for a wide array of compounds, including popular research peptide…
For anti-doping analysts and forensic toxicologists, this study validates a practical and ethical method for identifying new biomarkers of peptide abuse. Instead of relying on difficult-to-conduct human trials, labs c…
For anti-doping agencies, this research provides a validated method to significantly increase the speed and efficiency of screening for peptides like the TB-500 fragment. The ability to process **up to 96 samples simu…
This research provides a clear roadmap for anti-doping laboratories on how to effectively study the metabolism of unapproved peptides. By identifying human kidney microsomes and liver S9 fractions as the most effectiv…
This research highlights a critical, often overlooked, factor in analytical accuracy for peptide quantification, particularly in sensitive areas like doping analysis and biopharmaceutical research. The findings unders…
This study provides preliminary clinical evidence that **intra-articular BPC-157 injections are a viable and effective option for relieving knee pain from various etiologies.** For individuals exploring regenerative t…
Understanding the exact chemical structure of Thymosin Alpha-1 is an absolutely crucial first step for any scientific investigation into its potential biological roles or therapeutic applications. This foundational ch…
Establishing a standardized chemical identity through resources like PubChem is foundational for all subsequent research into TB-500. It prevents ambiguity and ensures that studies conducted globally on this peptide a…
The withdrawal of this study highlights the inherent challenges in conducting clinical trials, especially for complex conditions like metastatic colorectal cancer where new treatment strategies are desperately needed.…
A Phase 1/2 trial is recruiting to assess TB-500's safety, tolerability, and pharmacokinetics, alongside exploratory cardiovascular biomarkers, in stable ASCVD patients.
This simplified and highly sensitive testing method significantly enhances the ability of anti-doping agencies to detect a wide range of prohibited peptides like AOD-9604. For athletes using or considering these compo…